Evidence map›Paper›PMID 36532480›Full record

ArticleFrontiers in microbiology2022

Next-generation sequencing of a combinatorial peptide phage library screened against ubiquitin identifies peptide aptamers that can inhibit the

Małgorzata Lisowska, Fiona Lickiss, Maria Gil-Mir, Anne-Sophie Huart, Zuzanna Trybala, Luke Way, Lenka Hernychova, Adam Krejci, Petr Muller, Radovan Krejcir and 7 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Małgorzata LisowskaInternational Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.
Fiona LickissInternational Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.
Maria Gil-MirUniversity of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
Anne-Sophie HuartUniversity of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
Zuzanna TrybalaInternational Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.
Luke WayUniversity of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
Lenka HernychovaResearch Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Adam KrejciResearch Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Petr MullerResearch Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Radovan KrejcirResearch Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Igor ZhukowInstitute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.
Przemyslaw JurczakFaculty of Chemistry, University of Gdańsk, Gdańsk, Poland.
Sylwia Rodziewicz-MotowidłoFaculty of Chemistry, University of Gdańsk, Gdańsk, Poland.
Kathryn BallUniversity of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
Borivoj VojtesekResearch Centre for Applied Molecular Oncology, Masaryk Memorial Cancer Institute, Brno, Czechia.
Ted HuppUniversity of Edinburgh, Institute of Genetics and Molecular Medicine, Edinburgh, United Kingdom.
Umesh KalathiyaInternational Centre for Cancer Vaccine Science, University of Gdańsk, Gdańsk, Poland.
University of Gdańsk · PLMasaryk Memorial Cancer Institute · CZUniversity of Edinburgh · GBMRC Institute of Genetics and Molecular Medicine · GBInstitute of Biochemistry and Biophysics, Polish Academy of Sciences · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Defining dynamic protein-protein interactions in the ubiquitin conjugation reaction is a challenging research area. Generating peptide aptamers that target components such as ubiquitin itself, E1, E2, or E3 could provide tools to dissect novel features of the enzymatic cascade. Next-generation deep sequencing platforms were used to identify peptide sequences isolated from phage-peptide libraries screened against Ubiquitin and its ortholog NEDD8. In over three rounds of selection under differing wash criteria, over 13,000 peptides were acquired targeting ubiquitin, while over 10,000 peptides were selected against NEDD8. The overlap in peptides against these two proteins was less than 5% suggesting a high degree in specificity of Ubiquitin or NEDD8 toward linear peptide motifs. Two of these ubiquitin-binding peptides were identified that inhibit both E3 ubiquitin ligases MDM2 and CHIP. NMR analysis highlighted distinct modes of binding of the two different peptide aptamers. These data highlight the utility of using next-generation sequencing of combinatorial phage-peptide libraries to isolate peptide aptamers toward a protein target that can be used as a chemical tool in a complex multi-enzyme reaction.

Indexed as

aptamersmolecular dynamicsnext-generation sequencingphage-peptideprotein–peptide bindingubiquitin

Identifiers

PMID36532480
PMCPMC9755681
OpenAlexW4310542956

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.